Shaping A System That Enables Patients To Access High-Cost Cell & Gene Therapies

The industry recognizes that widespread patient access to cell and gene therapies will require current therapy-payment systems to change.?In our recent?perspectives, we detail the emerging operational steps to get there.


#patientaccess?#cellandgenetherapies?#cellandgene?#paymentsystems?#reimbursement?#centralfinancing?#healthoutcomes

要查看或添加评论,请登录

Sanjay Srivastava, PhD的更多文章

社区洞察

其他会员也浏览了